← Back
Data updated: Mar 29, 2026
HEC PHARM
Infectious DiseaseGastroenterologyCardiovascular
Generics
HEC PHARM is a generic drug manufacturer focused on Infectious Disease, Gastroenterology, Cardiovascular.
2011
Since
7
Drugs
-
Trials
138
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
FINGOLIMOD HYDROCHLORIDE 2026-02-24
Labeling
FINGOLIMOD HYDROCHLORIDE 2026-02-18
Labeling
FINGOLIMOD HYDROCHLORIDE 2026-02-18
Labeling
OLANZAPINE 2026-02-09
Labeling
OLANZAPINE 2026-02-09
Labeling
OLANZAPINE 2026-01-23
OLANZAPINE 2026-01-22
Labeling
FINGOLIMOD HYDROCHLORIDE 2026-01-16
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 25%
2 drugs
Gastroenterology 25%
2 drugs
Cardiovascular 25%
2 drugs
Respiratory 13%
1 drugs
Dermatology 13%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Gastroenterology, Respiratory
Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Dermatology, Respiratory
B BRAUN specialty
Infectious Disease, Dermatology, Cardiovascular
Discontinued (3)
Company Info
- First Approval
- 2011-10-07
- Latest
- 2024-09-20
- Applications
- 7
FDA Sponsor Names
HEC PHARMHEC PHARM CO LTD